Our aim was to assess the severity of anxiety in PLWHA in Mexico City and obtain the psychometric properties of the culturally-adapted Spanish version of GAD-7. Thirteen percent of participants presented moderate to severe symptoms. Reliability (α = 0.82) and construct validity (single-factor explained 48.9% of variance) were evaluated in 411 participants. Confirmatory Factor Analysis was performed in a second sample of 527 participants. Model fit adequately (CFI = 0.991; CMIN/DF = 1.924; RMSEA = 0.042; and SRMR = 0.026). The adapted version of GAD-7 was adequate for the assessment of anxiety in Mexican PLWHA.
AnthoineEMoretLRegnaultA, et al. (2014) Sample size used to validate a scale: A review of publications on newly-developed patient reported outcomes measures. Health and Quality of Life Outcomes12: 176.
2.
BakerAMHolbrookJTYohannesAM, et al. (2018) Test performance characteristics of the AIR, GAD-7, and HADS-anxiety screening questionnaires for anxiety in chronic obstructive pulmonary disease. Annals of the American Thoracic Society15: 926–934.
3.
BeardCBjörgvinssonT (2014) Beyond generalized anxiety disorder: Psychometric properties of the GAD-7 in a heterogeneous psychiatric sample. Journal of Anxiety Disorders28: 547–552.
4.
BeerLTieYPadillaM, et al. (2019) Generalized anxiety disorder symptoms among persons with diagnosed HIV in the United States. AIDS33: 1781–1787.
5.
BoatengGONeilandsTBFrongilloEA, et al. (2018) Best practices for developing and validating scales for health, social, and behavioral research: A primer. Frontiers in Public Health6: 149.
6.
BrandtCZvolenskyMJWoodsSP, et al. (2017) Anxiety symptoms and disorders among adults living with HIV and AIDS: A critical review and integrative synthesis of the empirical literature. Clinical Psychology Review51: 164–184.
7.
Caballero-SuárezNPRodríguez-EstradaECandela-IglesiasM, et al. (2017) Comparison of levels of anxiety and depression between women and men living with HIV of a Mexico City clinic. Salud Mental40(1): 15–22.
8.
Carrillo ValdezLEscamilla GutiérrezMLGonzález BaenaV (2020) Variables predictoras de las respuestas psicológicas ante Covid-19: un estudio en México. Ciencia Y Sociedad45: 7–23.
9.
ChibandaDVerheyRGibsonLJ, et al. (2016) Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. Journal of Affective Disorders198: 50–55.
10.
EvangeliMWroeAL (2017) HIV disclosure anxiety: A systematic review and theoretical synthesis. AIDS and Behavior21: 1–11.
11.
Galindo VázquezORamírez-OrozcoMCostas-MuñizR, et al. (2020) Síntomas de ansiedad, depresión y conductas de autocuidado durante la pandemia de COVID-19 en la población general. Gaceta Medica de Mexico156: 298–305. DOI: 10.24875/GMM.20000266
12.
García-CampayoJZamoranoERuizMA, et al. (2010) Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health and Quality of Life Outcomes8: 8.
13.
HerrNRWilliamsJWJrBenjaminS, et al. (2014) Does this patient have generalized anxiety or panic disorder? The rational clinical examination systematic review. The Journal of the American Medical Association312: 78–84.
14.
HeywoodWLyonsA (2016) HIV and elevated mental health problems: Diagnostic, treatment, and risk patterns for symptoms of depression, anxiety, and stress in a national community-based cohort of gay men living with HIV. AIDS and Behavior20: 1632–1645.
15.
HinzAKleinAMBrählerE, et al. (2017) Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample. Journal of Affective Disorders210: 338–344.
16.
International Test Commission (2017) The ITC Guidelines for Translating and Adapting Tests. International Test Commission, Hemel Hempstead, United Kingdom. www.InTestCom.org
17.
JohnsonSUUlvenesPGØktedalenT, et al. (2019) Psychometric properties of the General Anxiety Disorder 7-Item (GAD-7) Scale in a heterogeneous psychiatric sample. Frontiers in Psychology10: 1713.
18.
KertzSBigda-PeytonJBjorgvinssonT (2012) Validity of the Generalized Anxiety Disorder-7 Scale in an acute psychiatric sample. Clinical Psychology & Psychotherapy20(5): 456–464.
19.
KroenkeKSpitzerRLWilliamsJB (2001) The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine16(9): 606–613.
20.
LöweBDeckerOMüllerS, et al. (2008) Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Medical Care46(3): 266–274.
21.
MannesZLDunneEMFergusonEG, et al. (2021) Symptoms of generalized anxiety disorder as a risk factor for substance use among adults living with HIV. AIDS Care33: 623–632.
22.
MillsSDFoxRSMalcarneVL, et al. (2014) The psychometric properties of the Generalized Anxiety Disorder-7 scale in Hispanic Americans with English or Spanish language preference. Cultural Diversity & Ethnic Minority Psychology20: 463–468.
23.
MyerLSmitJRouxLL, et al. (2008) Common mental disorders among HIV-infected individuals in South Africa: Prevalence, predictors, and validation of brief psychiatric rating scales. AIDS Patient Care and Stds22: 147–158.
24.
NunnallyJC (1978) Phychometric theory. New York, NY: McGraw-Hill.
25.
RaoDKekwaletsweTCHosekS, et al. (2007) Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care19(1): 28–33.
26.
RoseMDevineJ (2014) Assessment of patient-reported symptoms of anxiety. Dialogues in Clinical Neuroscience16: 197–211.
27.
RutterLABrownTA (2017) Psychometric properties of the Generalized Anxiety Disorder Scale-7 (GAD-7) in outpatients with anxiety and mood disorders. Journal of Psychopathology and Behavioral Assessment39(1): 140–146.
28.
SchulteMTMarelichWDPayneDL, et al. (2018) Validation of a brief measure of HIV health-related anxiety among women living with HIV. Research in Nursing & Health41(4): 398–407. DOI: 10.1002/nur.21876
29.
ShachamEMorganJCÖnenNF, et al. (2012) Screening anxiety in the HIV clinic. AIDS and Behavior16: 2407–2413.
30.
SpitzerRLKroenkeKWilliamsJB, et al. (2006) A brief measure for assessing generalized anxiety disorder: The GAD-7. Archive of Internal Medicine166(10): 1092–1097.
31.
TerrillALHartoonianNBeierM, et al. (2015) The 7-item generalized anxiety disorder scale as a tool for measuring generalized anxiety in multiple sclerosis. International Journal of MS Care17(2): 49–56.
32.
TiirikainenKHaravuoriHRantaK, et al. (2019) Psychometric properties of the 7-item Generalized Anxiety Disorder Scale (GAD-7) in a large representative sample of Finnish adolescents. Psychiatry Research272: 30–35.
33.
Van der HeijdenIAbrahamsNSinclairD (2017) Psychosocial group interventions to improve psychological well-being in adults living with HIV. Cochrane Database of Systematic Reviews3(3): CD010806.
34.
YangZHuangXLiuX, et al. (2019) Psychometric properties and factor structure of the chinese version of the hospital anxiety and depression scale in people living with HIV. Frontiers in Psychiatry10: 346.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
